This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Chengdu New Radiomedicine Technology Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Qiang Ge: Innovator in Radiomedicine
Introduction
Qiang Ge is a prominent inventor based in Chengdu, China. He has made significant contributions to the field of radiomedicine, particularly through his innovative work on metal nuclide-loaded carbon microspheres.
Latest Patents
Qiang Ge holds a patent for a "Metal nuclide-loaded carbon microsphere (CMS), preparation method, and use thereof." This invention provides a method for preparing a metal nuclide-loaded CMS, which includes reacting a metal ion with a small organic molecule in an aqueous solution to form a complex. The CMS then adsorbs this complex and undergoes a first treatment. The resulting metal nuclide-loaded CMS can stably exist in an aqueous solution at temperatures below 180° C and pressures under 10 MPa, with a metal nuclide dissolution rate of less than 0.1%. Notably, after moist-heat sterilization at 121° C for 15 minutes, the radionuclide release rate remains below 0.1%, significantly reducing safety risks associated with radioactive microsphere products in clinical applications.
Career Highlights
Qiang Ge is affiliated with Chengdu New Radiomedicine Technology Co., Ltd., where he continues to advance research and development in radiomedicine. His work has garnered attention for its potential applications in clinical settings, particularly in enhancing the safety and efficacy of radiopharmaceuticals.
Collaborations
Qiang Ge collaborates with notable colleagues, including Jun Zhang and Maoliang Li, who contribute to the innovative projects at their company.
Conclusion
Qiang Ge's contributions to the field of radiomedicine through his patented innovations highlight his role as a key inventor in advancing medical technology. His work not only enhances the safety of radiopharmaceuticals but also paves the way for future developments in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile